In vivo spectroscopy for detection and treatment of GBM with NPt implantation

José de la Rosa, Diego Adrián Fabila, Luis Felipe Hernández, Edgard Moreno, Suren Stolik, Gabriela de la Rosa, Mayra Álvarez, Alfonso Arellano, Tessy López, R. Mercado, J. L. Soto, L. Arredondo, J. Bustos, A. Mosqueda, I. Rivero

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

3 Scopus citations

Abstract

Nowadays, cancer is one of the main human causes of death worldwide. In 2007, 7.9 million deaths were due to this disease. The World Health Organization (WHO) estimates that 84 million people will die in the 10 year period from 2005 to 2015 due to cancer (IARC, 2008). In Mexico, from 1922 to 2001, the increase in the cancer-related grew from 0.6 to 13.1% of all the deaths occurring in the overall population (Kuri et al., 2010). Cancer types vary from one country to another, and specialists estimate that if current tendencies are maintained, the rate of incidence will rise all over the world. Since the incidence of most cancers increases with age, these Figures are going to rise if life expectancy continues to increase.

Original languageEnglish
Title of host publicationNanomedicine and Cancer Therapies
PublisherApple Academic Press
Pages19-30
Number of pages12
ISBN (Electronic)9781466560086
ISBN (Print)9781926895185
DOIs
StatePublished - 1 Jan 2012

Keywords

  • Brain tumors
  • Fiber-optic probe
  • Glioblastoma multiformes
  • Masson
  • World health organization

Fingerprint

Dive into the research topics of 'In vivo spectroscopy for detection and treatment of GBM with NPt implantation'. Together they form a unique fingerprint.

Cite this